Gilead under scrutiny for drug pricing: Mass. AG By: CNBC.com News January 27, 2016 at 10:08 AM EST Massachusetts AG Maura Healey suggested the costs of two drugs "may constitute an unfair trade practice in violation of Massachusetts law." Read More >> Related Stocks: Gilead Sciences